Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Baxter International Inc (BAX)

Baxter International Inc (BAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Baxter International Inc One Baxter Parkway Deerfield IL 60015 USA

www.baxter.com Employees: 38,000 P: 224-948-2000 F: 877-334-2298

Sector:

Medical

Description:

Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.

Key Statistics

Overview:

Market Capitalization, $K 16,980,832
Enterprise Value, $K 28,342,832
Shares Outstanding, K 511,625
Annual Sales, $ 10,636 M
Annual Net Income, $ -649,000 K
Last Quarter Sales, $ 533,000 K
Last Quarter Net Income, $ -512,000 K
EBIT, $ 439,000 K
EBITDA, $ 1,911 M
60-Month Beta 0.60
% of Insider Shareholders 0.21%
% of Institutional Shareholders 90.19%
Float, K 510,551
% Float 99.79%
Short Volume Ratio 0.28

Growth:

1-Year Return -20.28%
3-Year Return -57.01%
5-Year Return -58.40%
5-Year Revenue Growth -6.39%
5-Year Earnings Growth -42.90%
5-Year Dividend Growth 22.35%

Per-Share Information:

Most Recent Earnings 0.58 on 02/20/25
Next Earnings Date 05/01/25
Earnings Per Share ttm 2.71
EPS Growth vs. Prev Qtr -27.50%
EPS Growth vs. Prev Year -34.09%
Annual Dividend Rate, $ 0.92
Annual Dividend Yield 2.77%
Most Recent Dividend 0.170 on 02/28/25
Next Ex-Dividends Date 02/28/25
Dividend Payable Date 04/01/25
Dividend Payout Ratio 39.96%
Most Recent Split 46-25 on 07/01/15

BAX Ratios

Ratio
Price/Earnings ttm 12.34
Price/Earnings forward 13.46
Price/Earnings to Growth 0.92
Return-on-Equity % 17.17%
Return-on-Assets % 4.98%
Profit Margin % -6.10%
Debt/Equity 1.87
Price/Sales 1.61
Price/Cash Flow 7.03
Price/Book 2.43
Book Value/Share 13.76
Interest Coverage -0.15

BAX Dividends

Date Value
02/28/25 $0.1700
11/29/24 $0.1700
08/30/24 $0.2900
05/31/24 $0.2900
02/29/24 $0.2900
11/30/23 $0.2900
08/31/23 $0.2900
06/01/23 $0.2900
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar